Instinct Bio Technical Company Holdings Inc. (BIOT)
NASDAQ: BIOT · Real-Time Price · USD
0.3670
-0.0203 (-5.24%)
At close: Aug 14, 2026, 4:00 PM EDT
0.3651
-0.0019 (-0.52%)
After-hours: Aug 14, 2026, 7:58 PM EDT
Company Description
Instinct Bio Technical Company Holdings Inc. focuses on stem cell and regenerative medicine-related products, wellness, and beauty encompassing from research and development, manufacturing, branding, and distribution.
The company was founded in 2011 and is headquartered in Tokyo, Japan.
Instinct Bio Technical Company Holdings Inc.
| Country | Japan |
| Founded | 2017 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Tomoki Nagano |
Contact Details
| Website | instinct-biot.com |
Stock Details
| Ticker Symbol | BIOT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 2072186 |
| CUSIP Number | G4860C107 |
| ISIN Number | KYG4860C1078 |
| SIC Code | 2844 |
Key Executives
| Name | Position |
|---|---|
| Dr. Michael Shleifer Ph.D. | Chairman and Chief Executive Officer |
| Thomas Fratacci | Chief Financial Officer and Treasurer |
| Ivan Jarry | Chief Operating Officer |
| Albert F. Hummel M.B.A. | Chief Investment Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 26, 2026 | 425 | Filing |
| Dec 3, 2025 | EFFECT | Notice of Effectiveness |
| Nov 25, 2025 | POS AM | Post-Effective amendments for registration statement |
| Oct 24, 2025 | F-4/A | Filing |
| Sep 26, 2025 | F-4/A | Filing |
| Sep 17, 2025 | 425 | Filing |
| Sep 9, 2025 | F-4 | Filing |
| Aug 12, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Jun 23, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Jun 13, 2025 | DRS | [Cover] Draft Registration Statement |